Exploding Capsules Promise Needle-Free⁣ Insulin Delivery, Revolutionizing Drug Absorption

Atlanta, GA ‍ – ‍A groundbreaking innovation from Georgia ⁤Tech researchers ⁢could⁣ soon make daily insulin injections a relic of the past. Scientists have ⁢developed a novel “exploding” capsule designed to deliver insulin and othre protein-based drugs orally, bypassing the need for needles and considerably improving drug absorption in‍ the intestine. This technology, inspired by jet injection methods used for ‍vaccinations, promises a more effective and patient-pleasant approach to⁢ managing conditions like diabetes.

The Science Behind the “Explosion”

The innovative capsule leverages a simple yet powerful chemical reaction to achieve its drug delivery goal.Once swallowed, the capsule, made from⁤ a strengthened gelatin similar to conventional pills, activates a bubbling reaction between water‍ and sodium bicarbonate.This process builds internal pressure within the capsule.

“The high velocity of the ‍’explosion’ sweeps away ⁤the mucus that lines the intestine much like a burst of air might shove water ⁤aside,” explains the⁣ research team. This high-speed expulsion of⁢ drug particles ensures they are placed⁣ directly adjacent to the epithelial cells responsible for transferring them into ‍the bloodstream. Crucially, the speed of this delivery mechanism prevents protein-eating enzymes from degrading⁤ the drug before it can⁣ be absorbed, a common problem ⁣with current oral protein drug delivery methods.

Overcoming Absorption Barriers

Many vital protein-based⁣ medications, including insulin and certain weight-loss drugs like semaglutide, are poorly absorbed when taken orally. ⁤The body⁢ typically utilizes less then 1% of orally administered semaglutide, with the vast majority being wasted. The Georgia Tech‍ capsule is engineered to dramatically increase this⁣ absorption rate.”The capsule itself is made of the same gelatin material as pills already in your medicine cabinet,” notes the study. “It’s been strengthened by exposure to ultraviolet light to help it stand up to the extreme⁣ environment in the stomach and ⁢small intestine.” This⁤ robust design ensures the capsule ⁤remains intact until it reaches the optimal delivery site in the intestine,where a small internal ⁤compartment positions the⁢ drug for efficient‍ ejection.

Integrating with Existing Manufacturing

A ⁢key objective for the research⁣ team was to ensure the new ‍technology could be seamlessly integrated into existing pharmaceutical manufacturing processes. “Right from the start, we set an objective to develop the capsule so it can plug right into conventional capsule manufacturing methods,” says Joshua Palacios, the study’s first ⁢author‍ and a former PhD student in Prausnitz’s lab.

“Obviously, ‍we’re doing a few things differently, but it’s critical to⁣ make these capsules ⁤at⁤ low cost⁢ and in large quantity,” Palacios emphasizes. “Leveraging existing⁤ manufacturing processes is key to making broad impact with ‍this technology.” This focus on scalability and cost-effectiveness⁣ is vital for making the treatment accessible to a wide patient ⁢population.

Inspiration from Skin⁣ Delivery

The concept for the ‍self-pressurizing capsule originated from the work ‍of Dr. Mark Prausnitz, a renowned pioneer in drug delivery, notably for ‍his work ⁤on microneedle patches for ⁣transdermal drug ⁤delivery. His research into delivering medications across⁣ the skin provided the inspiration for a similar ⁢approach within the gastrointestinal tract.

“I was⁢ thinking about all the⁢ different ways that we deliver medications across the skin and how this ⁢could be applicable in the intestine,” Prausnitz ⁣states. While various complex devices exist for skin delivery,they are too complex for oral administration. However, the principle of jet injection, already established for needle-free vaccinations, offered a viable model for the gut.

“there are some differences in⁢ the science and mechanism, but the thoght process is the same: You shoot something at high pressure against your target,” Prausnitz explains, drawing a parallel⁢ between delivering drugs through ‍the ‍skin and into the intestinal lining.

Future Directions and Potential Impact

The Georgia Tech team is actively working to ⁤further enhance the⁤ percentage of ⁢drug absorbed and is ⁤exploring the potential of their capsule for delivering other injectable⁢ medications, such ⁣as semaglutide, orally. This advancement holds immense promise ⁤for individuals managing chronic conditions like diabetes, offering a less ‍invasive and potentially more effective treatment option.By eliminating the need for injections, this technology could ⁣significantly improve patient adherence ⁢and quality of life.

**

Source: Georgia Tech*